J. Herrero

发表

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.

J. Prieto, B. Sangro, R. D. de Knegt, 2005, Journal of hepatology.

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

F. Jorquera, J. Calleja, J. Crespo, 2017, Journal of viral hepatitis.

Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.

J. Prieto, B. Sangro, J. Quiroga, 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

B. Sangro, J. Quiroga, J. Herrero, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Linezolid-Induced Lactic Acidosis in Two Liver Transplant Patients with the Mitochondrial DNA A2706G Polymorphism

J. Herrero, J. Banales, J. Yuste, 2014, Antimicrobial Agents and Chemotherapy.

Mitochondrial DNA A2706G Polymorphism Liver Transplant Patients with the Linezolid-Induced Lactic Acidosis in Two

J. Herrero, J. Banales, J. L. Pozo, 2014 .

Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events

J. Prieto, B. Sangro, J. Quiroga, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Applicability of living donor liver transplantation in a program of adult liver transplantation.

J. Quiroga, F. Rotellar, P. Martí, 2011, Transplantation proceedings.

Hepatitis B virus quasispecies evolution after liver transplantation in patients under long‐term lamivudine prophylaxis with or without hepatitis B immune globulin

M. Buti, J. Herrero, R. Esteban, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

First CT findings and improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury

M. Juncadella, J. Herrero, A. Gabarrós, 2009, Brain injury.

Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.

P. Martín-Dávila, J. Herrero, E. Cordero, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study

J. Martínez, J. Tur, J. Bressan, 2020, European Journal of Nutrition.

Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile

J. Tur, J. A. Martínez, I. Abete, 2018, International journal of molecular sciences.

Tuberculosis Prophylaxis With Levo fl oxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis : Safety Analysis of a Multicenter Randomized Trial

P. Martín-Dávila, J. Herrero, E. Cordero, 2015 .

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.

B. Sangro, J. Quiroga, F. Rotellar, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Randomized study showing the benefit of medical study writing multiple choice questions on their learning

J. Herrero, Felipe Lucena, Jorge Quiroga, 2019, BMC Medical Education.

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

J. Herrero, M. Rodríguez-Perálvarez, R. González‐Grande, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

J. Miro, A. Forner, I. Bilbao, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Risk factors for recurrence of hepatitis C after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Efficacy and safety of daclatasvir‐based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

J. Pascasio, J. Herrero, V. Cuervas-Mons, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry

M. Buti, M. L. de la Mata, J. Calleja, 2017, Hepatology.

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

B. Sangro, J. Herrero, J. Ruiz, 1992, Hepatology.

Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.

X. Forns, J. Pascasio, J. Montero, 2017, Journal of hepatology.

Effects of two personalized dietary strategies during a 2‐year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial

J. Martínez, J. Tur, J. Quiroga, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages

J. Prieto, B. Sangro, J. Quiroga, 2011, Annals of Surgical Oncology.

Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury

M. Juncadella, J. Herrero, A. Gabarrós, 2007, Brain injury.

Hyperhomocysteinemia in liver transplant recipients: Prevalence and multivariate analysis of predisposing factors

B. Sangro, J. Quiroga, J. Herrero, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study

F. Milagro, J. Martínez, J. Tur, 2021, Diagnostics.

Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation

C. Müller, J. Herrero, L. Martínez-Alarcón, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

D. Serón, J. Herrero, J. Morales, 2014, Transplantation reviews.

Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study

F. Milagro, J. Martínez, J. Tur, 2021, European Journal of Nutrition.

Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease

F. Milagro, J. Martínez, J. Tur, 2020, Nutrients.

Web-based formative assessment through clinical cases: role in pathophysiology teaching

J. Herrero, M. Landecho, M. Iñarrairaegui, 2021, BMC medical education.

A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids

J. Herrero, V. Cuervas-Mons, A. Rimola, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents.

J. Herrero, J. Castilla, J. Zozaya, 2020, Gastroenterologia y hepatologia.

Flipped classroom improves results in pathophysiology learning: results of a nonrandomized controlled study.

J. Herrero, Jorge Quiroga, 2019, Advances in physiology education.

Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters

B. Sangro, J. Quiroga, J. Herrero, 1995, Hepatology.

Self-expandable prostheses in the tracheobronchial tree.

A. Didier, H. Rousseau, I. Bilbao, 1993, Radiology.

Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents

J. Herrero, J. Castilla, J. Zozaya, 2020, Gastroenterología y Hepatología (English Edition).

Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals

J. Quiroga, J. Herrero, J. Bilbao, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.

J. Martínez, N. Bandarra, J. Tur, 2020, Journal of clinical lipidology.

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

J. Prieto, J. Herrero, C. Berasain, 2000, Gut.

Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

B. Sangro, J. Quiroga, M. Ávila, 2015, Liver international : official journal of the International Association for the Study of the Liver.

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2009, Hepato-gastroenterology.

A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.

J. Prieto, B. Sangro, J. García-Foncillas, 2003, Gastroenterology.

Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study

J. Martínez, J. Tur, I. Abete, 2019, Nutrients.

Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.

J. Pascasio, J. Herrero, M. Londoño, 2016, Transplantation proceedings.

Evaluation of the quality of multiple-choice questions according to the students’ academic level

J. Herrero, N. Fernández-Ros, M. Landecho, 2022, BMC Medical Education.

Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters

J. Prieto, B. Sangro, J. Quiroga, 1995, Hepatology.

Prophylaxis and treatment of hepatitis B infection in the setting of liver transplantation.

J. Herrero, D. D’Avola, 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence.

M. Buti, J. Herrero, R. Esteban, 2007, Transplantation.

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.

M. Buti, J. Herrero, C. García-rey, 2003, Journal of hepatology.

Pretransplant Portal Vein Recanalization—Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis

M. Abecassis, D. Ganger, T. Baker, 2015, Transplantation.

Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard‐dose or reduced‐dose tacrolimus in liver transplant recipients

P. Neuhaus, F. Durand, J. Klempnauer, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Interventional therapeutic techniques in Budd-Chiari syndrome

J. Herrero, J. Bilbao, A. Benito, 1997, CardioVascular and Interventional Radiology.

Effectiveness of Aprotinin in Orthotopic Liver Transplantation

B. Sangro, J. Quiroga, J. Paramo, 1993, Seminars in thrombosis and hemostasis.

Impact of non-neurological complications in severe traumatic brain injury outcome

J. Herrero, J. Ventura, C. Javierre, 2012, Critical Care.

New concepts and best practices for management of pre- and post-transplantation cancer.

D. Serón, J. Herrero, J. Morales, 2012, Transplantation reviews.

De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

J. Prieto, B. Sangro, J. Quiroga, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: A comparison of dual vs. triple drug therapy

J. Herrero, P. Parrilla Paricio, M. Gómez Gutiérrez, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Older age and liver transplantation

B. Sangro, J. Quiroga, J. Herrero, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

Fernando Pardo, Jesús Prieto, Bruno Sangro, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.

M. Buti, M. L. de la Mata, J. Herrero, 2005, Transplantation proceedings.

Prognostic model for early acute rejection after liver transplantation

J. Prieto, B. Sangro, J. Quiroga, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial

J. Martínez, J. Tur, J. Quiroga, 2019, Nutrients.

Hepatic venous outflow obstruction after transplantation: outcomes for treatment with self-expanding stents.

F. Rotellar, J. Herrero, J. Bilbao, 2015, Radiologia.

Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1997, Transplantation.

Hepatic venous outflow obstruction after transplantation: Outcomes for treatment with self-expanding stents☆

F. Rotellar, J. Herrero, J. Bilbao, 2015 .

[Reduction of the need for blood derivatives in liver transplantation using aprotinin].

J. Paramo, J. Herrero, P. Monedero, 1995, Revista espanola de anestesiologia y reanimacion.

Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation: A Spanish Matched Cohort Multicenter Study

J. Bruix, P. Parrilla, J. Herrero, 2014, Annals of surgery.

Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study.

I. Bilbao, J. Herrero, V. Cuervas-Mons, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.

Marie E. Edwards, V. Tasic, A. Chapman, 2016, American journal of human genetics.

Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation.

P. Martí, J. Herrero, J. Rifón, 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Graft-versus-host disease after liver transplantation.

J. Prieto, J. Quiroga, J. Herrero, 1993, Journal of the American Academy of Dermatology.

Prognostic factors and prevention of radioembolization‐induced liver disease

J. Prieto, B. Sangro, J. Quiroga, 2013, Hepatology.

Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

E. Andreu, F. Prósper, J. Prieto, 2017, Translational research : the journal of laboratory and clinical medicine.

Transjugular Intrahepatic Portosystemic Shunt (TIPS): Current Status and Future Possibilities

J. Quiroga, J. Herrero, J. Bilbao, 2002, CardioVascular and Interventional Radiology.

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls

F. Milagro, J. Martínez, J. Tur, 2019, Nutrients.

Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease

M. Falip, Á. Iranzo, S. Boluda, 2010, Epileptic disorders : international epilepsy journal with videotape.

Ascites due to anastomotic stenosis after liver transplantation using the piggyback technique: Treatment with endovascular prosthesis

J. Quiroga, J. Herrero, J. Bilbao, 2000, CardioVascular and Interventional Radiology.

Gastrointestinal complications in liver transplant recipients: MITOS study.

I. Bilbao, J. Herrero, M. Rodríguez, 2007, Transplantation proceedings.

Percutaneous transhepatic treatment of a posttransplant portal vein thrombosis and a preexisting spontaneous splenorenal shunt

J. Quiroga, J. Herrero, J. Bilbao, 1995, CardioVascular and Interventional Radiology.

Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis.

J. Herrero, J. Yuste, J. L. Del Pozo, 2019, The Journal of antimicrobial chemotherapy.

Efficacy of laparoscopic approach in the management of early liver transplant complications.

F. Rotellar, P. Martí, J. Herrero, 2012, Transplantation proceedings.

Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.

B. Sangro, J. Quiroga, F. Rotellar, 2012, Transplantation proceedings.

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

J. Herrero, A. Aldaz, J. Cortijo, 2015, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver Transplantation.

B. Sangro, J. Quiroga, F. Rotellar, 2017, Annals of transplantation.

Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients

I. Bilbao, J. Herrero, M. Mata, 2015, Clinical transplantation.

Case Report: Effectiveness of Lamivudine in Treatment of Acute Recurrent Hepatitis B After Liver Transplantation

J. Prieto, B. Sangro, J. Quiroga, 1998, Digestive Diseases and Sciences.

Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1998, Digestive diseases and sciences.

Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma

B. Sangro, J. Quiroga, J. Herrero, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study

J. Martínez, J. Tur, I. Abete, 2020, Diagnostics.

[Factors modulating food intake and energy expenditure prior to liver transplantation].

G. Frühbeck, J. Quiroga, J. Salvador, 2016, Anales del Sistema Sanitario de Navarra.

Rhabdomyolysis after Intentional Acetaminophen and Carbon Monoxide Poisoning

B. Sangro, J. Quiroga, J. Herrero, 2012 .

Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients

J. Herrero, P. Ramírez, L. Martínez-Alarcón, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver transplant recipients have an increased risk of developing colorectal adenomas: Results from a retrospective study

J. Herrero, Estefanía Toledo, M. Betés, 2020, Clinical transplantation.

Lung cancer screening with low-radiation dose computed tomography after liver transplantation.

G. Bastarrika, J. Quiroga, J. Herrero, 2013, Annals of transplantation.

Efficacy and Toxicity of Intra-Arterial Cisplatin and Etoposide for Advanced Hepatocellular Carcinoma

J. Prieto, B. Sangro, J. Quiroga, 2002, Oncology.

Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 2001, Digestive Diseases and Sciences.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

J. Miro, A. Forner, I. Bilbao, 2016, Hepatology.

Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression.

F. Pérez-Sanz, J. Herrero, P. Ramírez, 2019, Transplantation.

Expression of Wilms' tumor suppressor in the liver with cirrhosis: Relation to hepatocyte nuclear factor 4 and hepatocellular function

J. Prieto, M. Ávila, J. Herrero, 2003, Hepatology.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

J. Prieto, B. Sangro, J. Quiroga, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults

J. Martínez, J. Tur, J. Quiroga, 2019, International journal of medical sciences.

Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

Aaron S. Gajadhar, B. Sangro, F. Corrales, 2023, BioFactors.

Both dual and triple regimens of tacrolimus are effective and safe in liver transplantation

P. Parrilla, J. Herrero, J. O. D. Urbina, 2001 .

The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT

B. Sangro, A. Casadei‐Gardini, J. Herrero, 2020, CardioVascular and Interventional Radiology.

A phase I clinical trial of intratumoral injection of adenovirus encoding interleukin-12 in patients with hepatocellular carcinoma and other advanced gastrointestinal tumors

J. Prieto, B. Sangro, J. Quiroga, 2003 .

Randomized study showing the benefit of medical study writing multiple choice questions on their learning

J. Herrero, Felipe Lucena, Jorge Quiroga, 2019, BMC medical education.

Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

B. Sangro, F. Rotellar, J. Herrero, 2023, Cancers.

Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2010, International journal of radiation oncology, biology, physics.

Hepatitis C virus (HCV) viremia in patients with hepatocellular carcinoma (HCC) detected by nested-PCR

J. Prieto, B. Sangro, J. Herrero, 1991 .

Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil

J. Herrero, V. Cuervas-Mons, D. D’Avola, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Risk factors and impact of portal vein thrombosis in liver transplantation.

J. Paramo, J. Herrero, F. Rotellar Sastre, 2019, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Tacrolimus is effective in both dual and triple regimens after liver transplantation.

P. Parrilla, J. Herrero, M. Gómez, 2002, Transplantation proceedings.

Increased liver stiffness values in patients with heart failure.

J. Prieto, B. Sangro, J. Quiroga, 2013, Acta gastro-enterologica Belgica.

Liver transplantation in cirrhotic patients over 60 years of age.

J. Prieto, B. Sangro, J. Quiroga, 1998, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients

M. L. de la Mata, J. Herrero, A. Cuadrado, 2017, Annals of transplantation.

[Comparison of the M and XL FibroScan(®) probes to estimate liver stiffness by transient elastography].

J. Prieto, B. Sangro, J. Quiroga, 2014, Gastroenterology & hepatology.

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents.

J. Herrero, J. Castilla, I. Martínez-Baz, 2019, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial (final report Maag Lever Darm Stichting projectno. WS 00???78 (WS 97/87))

J. Prieto, B. Sangro, J. Frystyk, 2006 .

[Consensus document on indications for liver transplantation. 2002].

J. Figueras, L. Grande, M. L. de la Mata, 2003, Gastroenterologia y hepatologia.

Immunophenotypic Pattern of De Novo Malignancy After Liver Transplantation.

B. Paiva, J. Herrero, A. Zabaleta, 2019, Transplantation proceedings.

Is liver biopsy necessary in the evaluation of a living donor for liver transplantation?

F. Rotellar, P. Martí, J. Herrero, 2014, Transplantation proceedings.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

B. Sangro, J. Quiroga, F. Rotellar, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Subsequent nonmelanoma skin cancer after liver transplantation.

B. Sangro, F. Rotellar, J. Herrero, 2012, Transplantation proceedings.